Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INMT | O95050 | 4/20 | 0.91 |
| ▸ | USP2 | O75604 | 2/20 | 0.91 |
| ▸ | NOS3 | P29474 | 5/20 | 0.41 |
| ▸ | NOS1 | P29475 | 5/20 | 0.41 |
| ▸ | NOS2 | P35228 | 5/20 | 0.41 |
| ▸ | ACHE | P22303 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL496207 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL6859113 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL5475300 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL2956216 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL3270217 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL2956214 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL6038391 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL2742282 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL20718625 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 | |
| SCHEMBL2952223 | 1.00 | INMT (0.91) | INMTUSP2NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2762240-B1 | METHOD FOR FORMING COATING FILM AND COATED ARTICLE | KANSAI PAINT CO LTD (JP) | 2020-11-04 | — | — | EP | claimed |
| EP-3494162-B1 | NON-TIN CATALYST FOR CURING ALKOXYSILYL-CONTAINING POLYMER | MOMENTIVE PERFORMANCE MAT INC (US) | 2020-06-03 | — | — | EP | claimed |
| US-20090011124-A1 | Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(1-methylimidazole)2(2-ethylhexanoate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes | HSIEH BING | 2009-01-08 | — | — | US | claimed |
| US-20060247341-A1 | Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes | KING INDUSTRIES, INC. | 2006-11-02 | — | — | US | claimed |
| US-20060036007-A1 | Organometallic compositions and coating compositions | KING INDUSTRIES, INC. (US) | 2006-02-16 | — | — | US | claimed |
| US-20250236755-A1 | COATING COMPOSITION AND METHOD FOR FORMING COATING FILM | KANSAI PAINT CO., LTD. (JP) | 2025-07-24 | — | — | US | disclosed |
| EP-4481009-A1 | COATING COMPOSITION AND METHOD FOR FORMING COATING FILM | Kansai Paint Co., Ltd. (JP) | 2024-12-25 | — | — | EP | disclosed |
| CN-118829697-A | Coating composition and coating film forming method | 关西涂料株式会社 | 2024-10-22 | — | — | CN | disclosed |
| WO-2023157942-A1 | COATING COMPOSITION AND METHOD FOR FORMING COATING FILM | 関西ペイント株式会社 | 2023-08-24 | — | — | WO | disclosed |
| WO-2022129138-A1 | NON-IONIC HYDROPHILIZED POLYISOCYANATES, CATALYSIS WITH ZINC COMPLEXES | COVESTRO DEUTSCHLAND AG (DE) | 2022-06-23 | — | — | WO | disclosed |
| EP-4015547-A1 | NONIONICALLY HYDROPHILICIZED POLYISOCYANATES, CATALYSIS WITH ZINC COMPLEXES | Covestro Deutschland AG (DE) | 2022-06-22 | — | — | EP | disclosed |
| EP-3362499-B1 | SYSTEMS AND METHODS FOR FORMING POLYURETHANES | EASTMAN CHEM CO (US) | 2021-09-22 | — | — | EP | disclosed |
| EP-2762541-A1 | COATING COMPOSITION AND COATED ARTICLE | Kansai Paint Co., Ltd (JP) | 2014-08-06 | — | — | EP | disclosed |
| US-20120225982-A1 | COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME | KING INDUSTRIES, INC. | 2012-09-06 | — | — | US | disclosed |
| US-20120070569-A1 | ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS | KING INDUSTRIES, INC. (US) | 2012-03-22 | — | — | US | disclosed |
| US-8088846-B2 | Organometallic compositions and coating compositions | KING INDUSTRIES, INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-7485729-B2 | Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes | KING INDUSTRIES, INC. (US) | 2009-02-03 | — | — | US | disclosed |
| US-20090011124-A1 | Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(1-methylimidazole)2(2-ethylhexanoate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes | HSIEH BING | 2009-01-08 | — | — | US | disclosed |
| US-20060247341-A1 | Complexes of zinc with substituted amidines and guanidines and aliphatic carboxylates, e.g., Zn(1-methylimidazole)2(acetate)2 and Zn(tetramethylguanidine)2(formate)2; useful as catalysts for deblocking blocked isocyanates and in the production of urethanes and polyurethanes | KING INDUSTRIES, INC. | 2006-11-02 | — | — | US | disclosed |
| US-20060036007-A1 | Organometallic compositions and coating compositions | KING INDUSTRIES, INC. (US) | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120070569-A1 | ORGANOMETALLIC COMPOSITIONS AND COATING COMPOSITIONS | UROD, AOC1, AOC2 | INMT 56/4885USP2 221/4885NOS3 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.